We further showed that PMEPA1 gene expression was reduced or absent in about 65% of prostate tumors and methylation of the PMEPA1 gene promoter was one of the major mechanisms of silencing PMEPA1 in prostate cancer [16,17,18]. This evidence concerns the gene PMEPA1 and prostate carcinoma.